Pfizer had recently sent out an information letter detailing the risks involved with Bextra use. Bextra is used to treat osteoarthritis, adult rheumatoid arthritis and menstrual cramping pain. Pfizer states that the drug shouldn't be used prior to or following surgery if it can be avoided due to risk of cardiovascular events such as heart attacks and strokes, lung blood clots, leg blood clots and infections. Bextra may also have the side effect of serious skin reactions such as toxic epidermal necrolysis, Stevens-Johnson Syndrome and erythema multiforme. Some of these conditions may lead to death. Bextra use should be discontinued if the patient develops a skin rash, mucosal lesions, mouth sores, breathlessness, wheezing, chest tightness or an allergic reaction. Some of these conditions may require urgent medical attention.
Source: summary of medical news story as reported by Canada Newswire
About: Pfizer releases Bextra risks information
Date: 11 December 2004
Source: Canada Newswire
URL:
http:/ This summary article refers to the following medical categories:
What do you think about the features of this website?
Take our user survey and have your say:
Tools & Services:
Medical Articles:
Related Medical Topics
» Next page: Pharmaceutical company wins one case and pays $250,000 in another diet drug case
Rate This Website
Medical Tools & Articles:
Forums & Message Boards
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.
